Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan 2;4(2):157-171.
doi: 10.1002/hep4.1460. eCollection 2020 Feb.

Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics

Affiliations
Review

Hepatitis B and Pregnancy: Virologic and Immunologic Characteristics

Shivali S Joshi et al. Hepatol Commun. .

Abstract

The hepatitis B virus (HBV) is an important human pathogen. Unvaccinated infants infected through mother-to-child transmission (MTCT) are at >95% risk of developing serum hepatitis B surface antigen-positive chronic hepatitis B (CHB). Despite complete passive-active HBV immunoprophylaxis, approximately 10% of infants born to mothers who are highly viremic develop CHB, and thus maternal treatment with nucleos(t)ide analogs (tenofovir disoproxil fumarate, lamivudine, or telbivudine) is recommended in the third trimester of pregnancy to reduce MTCT risk. Viral rebound usually occurs after stopping treatment and, in the context of maternal immunologic reconstitution postpartum, can also precipitate host immune-mediated hepatic (biochemical) flares. In this article, we review the epidemiology of HBV MTCT, discuss management and potential mechanisms of HBV vertical transmission, and highlight recent studies on virologic and immunologic aspects of hepatitis B in pregnancy and postpartum.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of proposed modes of HBV MTCT and underlying mechanisms. Abbreviation: ASGPR, asialoglycoprotein receptor.
Figure 2
Figure 2
Schematic representation of immunologic changes in the peripartum period in mothers with CHB and their infants.

References

    1. World Health Organization . Global health sector strategy on viral hepatitis 2016‐2021. https://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/. Published June 2016. Accessed September 2019.
    1. World Health Organization . Hepatitis B. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Published July 18, 2019. Accessed August 2019.
    1. Chang MS, Nguyen MH. Epidemiology of hepatitis B and the role of vaccination. Best Pract Res Clin Gastroenterol 2017;31:239‐247. - PubMed
    1. Tran TT. Hepatitis B in pregnancy. Clin Infect Dis 2016;62(Suppl. 4):S314‐S317. - PMC - PubMed
    1. Coffin CS, Fung SK, Alvarez F, Cooper CL, Doucette KE, Fournier C, et al. Management of hepatitis B virus infection: 2018 guidelines from the Canadian Association for the Study of Liver Disease and Association of Medical Microbiology and Infectious Disease Canada. Can Liver J 2018;1:156‐217. - PMC - PubMed